Funding for this research was provided by:
Ligue Contre le Cancer
Received: 18 January 2021
Accepted: 19 March 2021
First Online: 12 April 2021
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This prospective study was approved by the North-west Committee for the Protection of Persons (ref CPP 02/008/2014). The EudraCT number is 2015–000757-20 and the National Clinical Trial identifier is NCT02490891. All patients signed written consent prior to inclusion.
: Not applicable.
: All authors declare that they have no competing interests.